Scudeletti M, Indiveri F, Pierri I, Picciotto A, Ferrone S
Cell Immunol. 1986 Oct 1;102(1):227-33. doi: 10.1016/0008-8749(86)90341-2.
The expression of HLA Class II antigens by resting and phytohemagglutinin (PHA)-activated T cells and their functional properties in autologous mixed-lymphocyte reactions (MLR) were investigated in patients with chronic active hepatitis, with alcoholic cirrhosis, and with primary biliary cirrhosis. In all groups of patients the percentage of resting T cells expressing HLA Class II antigens was significantly higher than that in controls. The percentage of T cells which acquired HLA Class II antigens following PHA stimulation was reduced in patients with chronic active hepatitis, serum hepatitis B surface antigen (HBsAg) positive, and in those with alcoholic cirrhosis, HBsAg negative, although the level of [3H] thymidine incorporation was within normal limits. The degree of proliferation in autologous MLR with PHA-T cells was significantly reduced in patients with chronic active hepatitis, HBsAb positive, and in those with alcoholic cirrhosis, HBsAg positive. A reduced proliferation was also detected in autologous MLR with non-T cells, in patients with chronic active hepatitis, HBsAg positive. The abnormalities of autologous MLR are selective, since the proliferative and stimulatory activities of cells from patients with chronic liver diseases in allogeneic MLR were within normal ranges. The immunoregulatory role of HLA Class II antigens and of autologous MLR suggests that the abnormalities we have identified may play a role in the immunological dysfunctions underlying chronic liver diseases.
对慢性活动性肝炎、酒精性肝硬化和原发性胆汁性肝硬化患者静息及经植物血凝素(PHA)激活的T细胞上HLAⅡ类抗原的表达及其在自体混合淋巴细胞反应(MLR)中的功能特性进行了研究。在所有患者组中,表达HLAⅡ类抗原的静息T细胞百分比显著高于对照组。慢性活动性肝炎且血清乙肝表面抗原(HBsAg)阳性的患者以及酒精性肝硬化且HBsAg阴性的患者,PHA刺激后获得HLAⅡ类抗原的T细胞百分比降低,尽管[3H]胸腺嘧啶核苷掺入水平在正常范围内。慢性活动性肝炎且HBsAb阳性的患者以及酒精性肝硬化且HBsAg阳性的患者,PHA-T细胞在自体MLR中的增殖程度显著降低。慢性活动性肝炎且HBsAg阳性的患者,非T细胞在自体MLR中的增殖也降低。自体MLR的异常具有选择性,因为慢性肝病患者细胞在同种异体MLR中的增殖和刺激活性在正常范围内。HLAⅡ类抗原和自体MLR的免疫调节作用表明,我们所发现的异常可能在慢性肝病潜在的免疫功能障碍中起作用。